Protagonist Therapeutics Inc buy BTIG Research
Start price
28.10.25
/
50%
€66.00
Target price
28.10.26
€70.34
Performance (%)
29.55%
Price
04.05.26
€85.50
Summary
This prediction is currently active. The BUY prediction by BTIG_Research currently has a performance of 29.55%. This prediction currently runs until 28.10.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -1.156% | -1.156% |
| iShares Core DAX® | 4.642% | 7.489% |
| iShares Nasdaq 100 | 4.471% | 16.803% |
| iShares Nikkei 225® | 7.670% | 16.856% |
| iShares S&P 500 | 2.472% | 9.903% |
Comments by BTIG_Research for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $82.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by BTIG_Research for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
24.07.24
24.07.24
€46.93
24.07.25
24.07.25
-4.16%
25.07.25
25.07.25
